Charles Schwab Corporation
SCHW
$107.31
+0.06%
The Charles Schwab Corporation is a leading US retail-oriented financial services company operating across brokerage, banking, asset management, custody, financial advisory, and wealth management, with $11.9 trillion in client assets as of year-end 2025. It is best known for its retail brokerage franchise but generates the majority of revenue and profits through Charles Schwab Bank and its asset management arm, and it holds a dominant position in Registered Investment Advisor (RIA) custody with over 40% market share. The current investor narrative centers on a powerful earnings recovery driven by balance-sheet repositioning and higher-for-longer interest rates, with quarterly EPS climbing from $0.66 in mid-2024 to $1.37 in Q1 2026 and revenue growth reaccelerating to nearly 10% year over year. Debate among investors focuses on whether this margin expansion is sustainable as rate policy evolves, how Schwab defends its RIA custody moat against aggressive digital challengers like Robinhood and Interactive Brokers, and whether the stock's premium multiple still leaves room for upside after a strong multi-quarter run.…
SCHW
Charles Schwab Corporation
$107.31
Related headlines
Investment Opinion: Should I buy SCHW Today?
Rating: Buy. The core thesis is that Schwab is transitioning from a recovery story to a compounding growth story, with EPS up 108% from Q2 2024 to Q1 2026 and a forward PE of 13.74x that is undemanding relative to consensus EPS of $10.25. The analyst consensus rating of 'buy' with a recommendation mean of 1.73 and an average target price of $124.95 implies 16.5% upside, providing a favorable risk/reward skew for investors with a 12-18 month horizon.
The supporting evidence is compelling: revenue grew 9.77% year over year in Q1 2026 to $7.30 billion, with sequential growth in each of the last four quarters; net margin expanded to 33.96% from 28.71% a year ago; trailing free cash flow of $9.72 billion comfortably funds $2.38 billion in quarterly buybacks and $632 million in dividends; and the PEG ratio of 0.38 is strikingly low. Compared to the broader capital markets sector, where many brokerage peers trade at forward multiples in the high teens to low twenties, Schwab's forward PE of 13.74x represents a notable discount given its 17.91% ROE, 33.96% net margin, and dominant 40%+ RIA custody market share.
The biggest risks that could invalidate the thesis are: (1) a sharp decline in interest rates compressing net interest margin, which would pressure the $3.96 billion quarterly interest income; (2) accelerated competitive share loss to Robinhood and Interactive Brokers, which grew accounts 34% year over year; and (3) a broader market de-rating that compresses the price-to-book multiple from its current 3.58x. The rating would upgrade to a stronger Buy if the forward PE compresses below 12x while EPS estimates hold, or downgrade to Hold if revenue growth decelerates below 5% or net margin falls below 30%. At 21.35x trailing PE and 3.58x price-to-book, the stock is fairly valued relative to its own history but undervalued relative to its growth trajectory and peer group, leaving room for multiple expansion if margin expansion persists.
Sign up to view all
SCHW 12-Month Price Forecast
Schwab presents a compelling bullish case anchored by a powerful earnings inflection, expanding margins, and a forward PE of 13.74x that appears undemanding relative to consensus growth. The company's 17.91% ROE, 33.96% net margin, and $9.72 billion in trailing free cash flow reflect a high-quality franchise with scale advantages in RIA custody and retail brokerage. However, the investment thesis is heavily dependent on interest rates remaining higher for longer, and competitive threats from Robinhood and Interactive Brokers are intensifying, as evidenced by their 34% account growth. The wide analyst target spread from $91 to $145 signals meaningful disagreement about the pace of earnings normalization, and the stock's 1-year relative underperformance versus SPY suggests the market is waiting for clearer evidence on margin durability. I would upgrade to high confidence if Q2 2026 earnings show EPS above $1.45 with net margin holding above 33%, or downgrade to neutral if revenue growth decelerates below 5% or net interest margin compresses by more than 20 basis points.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Charles Schwab Corporation's 12-month outlook, with a consensus price target around $124.95 and implied upside of +16.4% versus the current price.
Average Target
$124.95
0 analysts
Implied Upside
+16.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$91 - $145
Analyst target range
Schwab is covered by 20 analysts with a consensus recommendation of "buy" and a recommendation mean of 1.73 (where 1.0 is a strong buy and 5.0 is a sell), indicating a clearly bullish tilt. The average target price of $124.95 implies approximately 16.5% upside from the current price of $107.25, and the consensus EPS estimate of $10.25 with estimated revenue of $38.45 billion suggests analysts expect continued double-digit earnings growth. The bullish consensus is reinforced by recent institutional actions, with Morgan Stanley, Barclays, and UBS all maintaining Overweight or Buy ratings in July 2026 and no downgrades visible in the ratings history. The target range spans from a low of $91.00 (roughly 15.2% below the current price) to a high of $145.00 (about 35.2% above), a wide spread that signals meaningful disagreement about the pace of earnings normalization and rate sensitivity. The high target likely assumes sustained margin expansion, continued client asset growth, and multiple expansion toward the upper end of Schwab's historical PE band, while the low target appears to price in margin compression from falling rates, competitive pressure in retail brokerage, or a broader market de-rating. The tight clustering of recent ratings around Overweight and Buy, with no sell ratings and only one Neutral (Piper Sandler), suggests strong institutional conviction, though the wide target spread means position sizing should account for the possibility that the more conservative scenario plays out.
Drowning in data?
Find the real signal!
Bulls vs Bears: SCHW Investment Factors
The bull case currently has stronger evidence, anchored by a powerful earnings inflection (EPS up 108% from Q2 2024 to Q1 2026), expanding margins (net margin up 525 basis points year over year), and a forward PE of 13.74x that appears undemanding relative to consensus growth. The bear case rests primarily on rate sensitivity and competitive threats, but these are risks to the sustainability of growth rather than evidence of deterioration today. The single most important tension is whether Schwab's net interest margin can hold as rate policy evolves; if rates stay higher for longer, the forward PE discount is unjustified and the stock could re-rate toward the $145 high target, but if rate cuts compress margins, the low target of $91 becomes the relevant anchor. The stock's low beta of 0.753 and strong capital returns provide downside cushion, but the 1-year relative underperformance versus SPY suggests the market is waiting for clearer evidence on margin durability.
Bullish
- Earnings inflection is powerful and sustained: Quarterly EPS has climbed from $0.66 in Q2 2024 to $1.37 in Q1 2026, a 108% increase over eight quarters, with sequential EPS gains in each of the last five quarters. Q1 2026 net income of $2.48 billion rose 29.9% year over year from $1.91 billion, demonstrating that the recovery is not a one-off but a durable earnings ramp.
- Forward PE of 13.7x is undemanding: The stock trades at a trailing PE of 21.35x but a forward PE of just 13.74x based on consensus EPS of $10.25, implying the market expects roughly 56% earnings growth over the next year. The PEG ratio of 0.38 is strikingly low, suggesting the stock is inexpensive relative to its earnings expansion trajectory.
- Margins are expanding sharply: Q1 2026 net margin reached 33.96%, up from 28.71% in Q1 2025, while gross margin improved to 88.79% from 84.20% and operating margin hit 43.67%. EBITDA margin of 48.23% in Q1 2026 reflects exceptional operating leverage as revenue growth outpaces expense growth.
- Analyst consensus is strongly bullish: All 20 covering analysts have a consensus 'buy' rating with a recommendation mean of 1.73, and the average target price of $124.95 implies 16.5% upside from the current $107.25. Recent institutional actions from Morgan Stanley, Barclays, and UBS all maintained Overweight or Buy ratings with no downgrades visible.
Bearish
- Rate sensitivity threatens margin sustainability: Schwab's earnings recovery is heavily tied to higher-for-longer interest rates, with interest income of $3.96 billion in Q1 2026. If the Fed cuts rates, net interest margin could compress and client cash sorting could reverse, potentially stalling the EPS growth that justifies the forward PE of 13.74x.
- Valuation premium to book is elevated: The price-to-book ratio of 3.58x sits near the upper end of its historical range of 2.39x to 4.24x, leaving limited room for multiple expansion. The price-to-sales ratio of 6.40x and EV/EBITDA of 12.63x are moderate but not cheap for a financial with bank-like balance-sheet constraints.
- Competitive pressure from digital challengers: Robinhood now runs 13 revenue lines above $100 million annually and Interactive Brokers grew customer accounts 34% year over year, according to recent news. These agile competitors are eroding the retail brokerage moat, and the SEC's removal of the PDT rule could further accelerate retail trading share shifts.
- Relative performance has lagged the market: Despite a 17.73% three-month gain, the stock's 1-year return of 14.17% trails the S&P 500's 16.22%, producing a relative strength of -2.05% over the full period. The 1-month relative strength of -0.85% and YTD underperformance of -6.49% versus SPY suggest the market is not fully rewarding the earnings recovery.
SCHW Technical Analysis
Schwab is in a sustained uptrend, with the stock up 14.17% over the past year and 17.73% over the past three months, and at a current price of $107.25 it sits at approximately 76.2% of its 52-week range (52-week low of $83.96, 52-week high of $114.53). This positioning signals healthy momentum rather than overextension, as the stock has not yet challenged its highs despite the strong intermediate-term trend. The 15.25% six-month gain confirms the recovery has been durable rather than a brief spike, though the trailing 1-year return of 14.17% slightly lags the S&P 500's 16.22%, indicating the stock has been a modest relative underperformer over the full period even as it outperformed sharply in recent months. Recent momentum has cooled, with the stock down 1.91% over the past month versus a 1.06% decline in SPY, producing a relative strength of -0.85% and a slight divergence from the strong 3-month trend. This short-term pullback from the August high of $113.65 appears to be a consolidation within the broader uptrend rather than a reversal, especially given the 3-month relative strength of +14.69% versus SPY. The stock's beta of 0.753 indicates it is roughly 25% less volatile than the broader market, which supports a lower-risk position sizing profile but also means it may lag in sharp risk-on rallies. Key resistance sits at the 52-week high of $114.53, and a breakout above that level would confirm a fresh leg higher; support rests at the 52-week low of $83.96, with intermediate support likely near the $100 psychological level and the July consolidation zone around $100-$102. A breakdown below $100 would signal a deeper correction, while the maximum drawdown of -20.39% over the past year shows the stock is capable of meaningful pullbacks despite its low beta.
Beta
0.75
0.75x market volatility
Max Drawdown
-20.4%
Largest decline past year
52-Week Range
$84-$115
Price range past year
Annual Return
+14.7%
Cumulative gain past year
| Period | SCHW Return | S&P 500 |
|---|---|---|
| 1m | -3.4% | -2.0% |
| 3m | +14.6% | +1.4% |
| 6m | +15.0% | +15.0% |
| 1y | +14.7% | +15.7% |
| ytd | +5.7% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SCHW Fundamental Analysis
Schwab's revenue trajectory is clearly reaccelerating, with Q1 2026 revenue of $7.30 billion representing 9.77% year-over-year growth versus $6.65 billion in Q1 2025, and the sequential progression from $6.82 billion in Q2 2025 to $7.04 billion in Q3 2025 to $7.17 billion in Q4 2025 to $7.30 billion in Q1 2026 shows consistent upward momentum. The revenue mix is heavily weighted toward Investor Services at $9.92 billion versus Advisor Services at $2.55 billion, meaning the retail and banking-driven segments are the primary growth engine while the RIA custody franchise provides a stable, high-retention base. This accelerating top-line trend, combined with EPS growth from $0.99 in Q1 2025 to $1.37 in Q1 2026, implies the investment case is shifting from a recovery story to a compounding growth story, though the pace of future growth remains tied to interest rate conditions and client cash sorting behavior. Profitability is robust and expanding, with Q1 2026 net income of $2.48 billion on a net margin of 33.96%, up from $1.91 billion and a 28.71% net margin in Q1 2025, while gross margin improved to 88.79% from 84.20% over the same period. Operating margin stands at 41.41% on a trailing basis and reached 43.67% in Q1 2026, reflecting strong operating leverage as revenue growth outpaces expense growth. The net income ratio of 33.96% and EBITDA of $3.52 billion in Q1 2026 (48.23% EBITDA margin) are exceptional for the capital markets industry and reflect Schwab's scale advantages in brokerage and banking. Financial health is solid but requires nuance: the debt-to-equity ratio of 0.63 is moderate, ROE of 17.91% is strong for a financial, and trailing free cash flow of $9.72 billion provides ample internal funding capacity. However, the current ratio of 0.53 reflects the bank-like balance sheet where customer deposits and payables dominate, and quarterly operating cash flow is volatile ($7.34 billion in Q1 2026 versus -$763 million in Q4 2025) due to client cash movement and balance-sheet repositioning. The company returned capital aggressively in Q1 2026 with $2.38 billion in stock repurchases and $632 million in dividends, funded comfortably by operating cash flow, and the 26.31% payout ratio leaves room for continued shareholder returns.
Quarterly Revenue
$7.3B
2026-03
Revenue YoY Growth
+9.8%
YoY Comparison
Gross Margin
88.8%
Latest Quarter
Free Cash Flow
$9.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SCHW Overvalued?
Because Schwab is solidly profitable with trailing net income of $2.48 billion in the most recent quarter and positive EPS of $1.37, the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 21.35x and a forward PE of 13.74x, and the wide gap between these two figures implies the market expects significant earnings growth, consistent with the consensus EPS estimate of $10.25 for the forward period versus the current run-rate. The PEG ratio of 0.38 is strikingly low, suggesting that when adjusted for expected growth, the stock is inexpensive relative to its earnings expansion trajectory. On a peer comparison basis, Schwab's trailing PE of 21.35x and forward PE of 13.74x compare favorably to the broader capital markets sector, where many brokerage peers trade at forward multiples in the high teens to low twenties; the forward discount is notable given Schwab's scale, 17.91% ROE, and 33.96% net margin. The price-to-book ratio of 3.58x is a premium to book but reasonable for a franchise with dominant RIA custody share and consistent profitability, while the price-to-sales ratio of 6.40x and EV/EBITDA of 12.63x are moderate for a financial with Schwab's margin profile. The dividend yield of 1.32% is modest but well covered at a 26.31% payout ratio, adding a small income component to the total return case. Historically, Schwab's PE ratio has ranged from roughly 15.6x (Q1 2023) to 33.7x (Q4 2023), with the current 21.35x sitting in the middle of that band and well below the 2023 peak, while the price-to-book of 3.58x is near the upper end of its historical range (2.39x to 4.24x). This suggests the market is pricing in continued earnings recovery and balance-sheet normalization but is not yet extrapolating the most optimistic scenario, leaving room for multiple expansion if growth persists.
PE
21.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 16x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple
Investment Risk Disclosure
Schwab's financial risks are moderate but nuanced. The debt-to-equity ratio of 0.63 is manageable, but the current ratio of 0.53 reflects a bank-like balance sheet where customer deposits and payables dominate, leaving limited liquidity buffer if client cash sorting accelerates. Quarterly operating cash flow is highly volatile, swinging from -$763 million in Q4 2025 to $7.34 billion in Q1 2026, driven by client cash movement and balance-sheet repositioning. The 33.96% net margin and 17.91% ROE are strong, but they depend on interest income of $3.96 billion per quarter, which is directly tied to rate levels; a 100 basis point rate cut could compress net interest margin by an estimated 10-15 basis points, potentially reducing annual net income by several hundred million dollars. Additionally, the company's revenue mix is heavily weighted toward Investor Services at $9.92 billion versus Advisor Services at $2.55 billion, meaning retail and banking segments are the primary growth engine and any slowdown in retail engagement would disproportionately impact results.
Market and competitive risks are intensifying. The stock trades at a price-to-book of 3.58x, near the upper end of its historical range of 2.39x to 4.24x, leaving limited room for multiple expansion and increasing vulnerability to valuation compression if growth disappoints. The beta of 0.753 means the stock is roughly 25% less volatile than the market, but this also means it may lag in sharp risk-on rallies, as evidenced by the 1-year relative underperformance of -2.05% versus SPY. Competitive threats are real: Robinhood now runs 13 revenue lines above $100 million annually and Interactive Brokers grew customer accounts 34% year over year, while the SEC's removal of the PDT rule could accelerate retail trading share shifts toward lower-cost digital platforms. Regulatory headwinds, including potential changes to payment for order flow or fiduciary standards, could pressure Schwab's retail brokerage economics, and the wide analyst target spread from $91 to $145 signals meaningful disagreement about the pace of earnings normalization.
The worst-case scenario would involve a combination of rate cuts compressing net interest margin, accelerated client cash sorting, and competitive share loss in retail brokerage. In this scenario, EPS growth could stall, and the stock could retest its 52-week low of $83.96, representing a 21.7% decline from the current price of $107.25. The analyst low target of $91.00 implies a 15.2% downside, but a more severe outcome could see the stock fall to the $85-$90 range if forward EPS estimates are revised down toward $9.00 and the forward PE compresses to 10x. The maximum drawdown of -20.39% over the past year shows the stock is capable of meaningful pullbacks despite its low beta, and in a worst-case scenario, an investor could lose 15-22% from the current price, with the 52-week low of $83.96 serving as the ultimate downside anchor.
FAQ
The most severe risk is interest rate sensitivity: Schwab generates $3.96 billion in quarterly interest income, and a 150 basis point rate cut could compress net interest margin below 2.0%, potentially reducing annual EPS by 15-20%. The second risk is competitive disruption, as Robinhood now runs 13 revenue lines above $100 million annually and Interactive Brokers grew customer accounts 34% year over year, threatening Schwab's retail brokerage market share. The third risk is valuation compression: the price-to-book of 3.58x is near the upper end of its historical range, and a broader market de-rating could push the multiple toward the historical average of 3.0x, implying a stock price near $90. The fourth risk is regulatory, as potential changes to payment for order flow or fiduciary standards could pressure retail brokerage economics. Ranked by severity, rate sensitivity is the most immediate threat, followed by competitive disruption, valuation compression, and regulatory headwinds.
The 12-month forecast includes three scenarios: a bull case with 30% probability targeting $130-$145, a base case with 50% probability targeting $115-$130, and a bear case with 20% probability targeting $85-$95. The base case is most likely, assuming revenue grows 8-10% to $38.45 billion, net margin holds above 32%, and the Fed funds rate stabilizes between 3.5% and 4.5%, allowing the stock to trade toward the analyst average target of $124.95. The bull case requires rates to remain above 4.5% and EPS to exceed $1.45 per quarter, driving the stock toward the analyst high target of $145. The bear case would be triggered by aggressive rate cuts, accelerated client cash sorting, and competitive share loss, pushing the stock toward the analyst low target of $91.00 or the 52-week low of $83.96. The key assumption behind the base case is that net interest margin remains stable, which is supported by the current higher-for-longer rate environment.
SCHW appears fairly valued relative to its own history but undervalued relative to its growth trajectory and peer group. The trailing PE of 21.35x sits in the middle of its historical range of 15.6x to 33.7x, while the price-to-book of 3.58x is near the upper end of its historical range of 2.39x to 4.24x. However, the forward PE of 13.74x represents a notable discount to brokerage peers trading in the high teens to low twenties, despite Schwab's 17.91% ROE and 33.96% net margin. The PEG ratio of 0.38 is strikingly low, suggesting the market is not fully pricing in the expected 56% earnings growth implied by the gap between trailing and forward PE. The market appears to be pricing in continued earnings recovery and balance-sheet normalization but is not yet extrapolating the most optimistic scenario, leaving room for multiple expansion if growth persists. A re-rating toward the peer-group forward multiple of 18-20x would imply a stock price of $140-$150, well above the current $107.25.
From a risk/reward perspective, SCHW offers a favorable setup with 16.5% upside to the analyst average target of $124.95 and a forward PE of 13.74x that is undemanding relative to consensus EPS of $10.25. The biggest downside risk is a rate-cut-driven margin compression that could push the stock toward the analyst low target of $91.00, representing 15.2% downside, or the 52-week low of $83.96 for 21.7% downside. The stock's low beta of 0.753 and strong capital returns provide some cushion, but the 1-year relative underperformance versus SPY suggests the market is waiting for clearer evidence on margin durability. It is a good buy for investors with a 12-18 month horizon who believe interest rates will remain higher for longer and who are comfortable with the competitive risks from digital challengers. For short-term traders, the recent 1-month pullback of 1.91% and consolidation below the 52-week high of $114.53 suggest waiting for a breakout above that level before entering.
SCHW is best suited for long-term investment with a minimum holding period of 12-18 months, given its growth stage as a mature financial franchise transitioning from recovery to compounding growth. The beta of 0.753 indicates lower volatility than the market, making it appropriate for conservative portfolios, but the 1-month relative strength of -0.85% and YTD underperformance of -6.49% versus SPY suggest short-term trading would be challenging without a clear catalyst. The dividend yield of 1.32% with a 26.31% payout ratio provides a modest income component, but the primary total return driver is earnings growth and multiple expansion, which requires patience. Earnings visibility is moderate, with 20 analysts covering the stock and a consensus EPS estimate of $10.25, but the wide target range of $91 to $145 signals uncertainty that favors a longer horizon. A 12-18 month holding period would allow investors to capture the expected EPS growth toward $10.25 and potential multiple expansion toward the peer-group forward PE of 18-20x, while providing time for rate policy and competitive dynamics to clarify.
